Courtagen Life Sciences, Inc. to Partner with Tetracore Inc. in Biodefense Initiative
Published: Feb 09, 2012
WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences, Inc. (“Courtagen”), a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry, today announced that it has entered into a strategic collaboration with Tetracore, Inc. (“Tetracore”) to develop a next generation biothreat assay for identifying and diagnosing high priority biological agents in clinical and environmental samples. Some of the target agents include those which cause significant diseases such as anthrax and plague, as well as dangerous toxins such as ricin and botulinum. The combined effort will focus on addressing the critical need to quickly and accurately identify the pathogen while also quantifying the magnitude of the potential threat.